Multigene measurable residual disease assessment improves AML relapse risk stratification in autologous hematopoietic cell transplantation

We report here the largest study to date of adult AML patients tested for measurable residual disease (MRD) at the time of autologous hematopoietic cell transplantation (auto-HCT). Seventy-two adult patients transplanted between 2004–2013 at a single academic medical center (UCSF) were eligible for...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Mulé, Matthew P., Mannis, Gabriel N., Wood, Brent L., Radich, Jerald P., Hwang, Jimmy, Ramos, Nestor R., Andreadis, Charalambos, Damon, Lloyd, Logan, Aaron C., Martin, Thomas G., Hourigan, Christopher S.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072749/
https://ncbi.nlm.nih.gov/pubmed/27544285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.08.014
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki